Skip to main content
Log in

La liraglutide aumenta i tassi di gravidanza dopo IVF in donne obese con PCOS e scarsa risposta alle terapie di prima linea: uno studio pilota randomizzato

  • Novità in Endocrinologia
  • Published:
L'Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Bibliografia

  1. Conway G, Dewailly D, Diamanti-Kandarakis E et al. (2014) The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol 171(4):P1–29

    Article  CAS  PubMed  Google Scholar 

  2. Outeiriño-Iglesias V, Romaní-Pérez M, González-Matías LC et al. (2015) GLP-1 increases preovulatory LH source and the number of mature follicles, as well as synchronizing the onset of puberty in female rats. Endocrinology 156(11):4226–4237

    Article  CAS  PubMed  Google Scholar 

  3. Artunc-Ulkumen B, Pala HG, Pala EE et al. (2015) Exenatide improves ovarian and endometrial injury and preserves ovarian reserve in streptozocin induced diabetic rats. Gynecol Endocrinol 31(3):196–201

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrea Fabbri.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Infante, M., Fabbri, A. La liraglutide aumenta i tassi di gravidanza dopo IVF in donne obese con PCOS e scarsa risposta alle terapie di prima linea: uno studio pilota randomizzato. L'Endocrinologo 19, 331–332 (2018). https://doi.org/10.1007/s40619-018-00503-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-018-00503-y

Navigation